Skip to content
★ Sign in to follow
Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$51.7BHealth Care

Pharmaron Beijing Co., Ltd.: what insiders have been doing

Headquartered in Beijing, People's Republic of China, Pharmaron Beijing Co., Ltd. belongs to the Health Care sector and traces its origins to 2004. Its latest reported headcount is 25,088 employees (2025). Filings by its managers are published through HKEX. In the past year (22 October 2025 to 22 October 2026), 4 filings came from 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Over the last twelve months, not one insider purchase of Pharmaron Beijing Co., Ltd. stock was filed. Filings reach the HKEX feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (1,314 companies, median 4 filings), a count of 4 filings is typical.

For comparison within the same sector, see the insider buying recorded at UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Analyst consensus: bullish or bearish?

Analysts rate Pharmaron Beijing Co., Ltd. Strong Buy (bullish), based on 11 analysts. Average price target: HK$40.03.

Fundamental score
Ranked 13,963 of 26,897 companies
50.4
score / 100
Value
41
Quality
60
FCF yld1.1%
Earn yld3.2%
EV/EBITDA17.9x
ROE10%
Gross mgn35%
Net mgn12%
Debt/EBITDA2.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$26.40
Analyst consensus
11 analysts
Strong buy
HK$28.83Target HK$40.03(+52%)HK$62.43
Income statement
RevenueHK$14.1B
Gross profitHK$4.9B35% margin
EBITDAHK$3.3B23% margin
Net incomeHK$1.7B11.2% margin
Valuation
PER (trailing)25.6x
PER (forward)17.9x
P/Book2.5x
Beta0.68
Balance sheet & cash
Market capHK$51.7B
Total debtHK$7B
Free Cash FlowHK$552M
Debt / Equity41%
Profitability & ownership
ROE10.1%
ROA4.9%
% insiders6.3%
% institutions33.3%
Last declaration on 6 May 2026
Declarations4 total
  • ●
    DirectorExecutives
    0HKEX
    4,450,000 sharesShareXHKGHKEX:DA20260506E00308
  • ●
    DirectorExecutives
    0HKEX
    4,700,000 sharesShareXHKGHKEX:DA20260506E00307
  • ●
    DirectorExecutives
    0HKEX
    11,000,000 sharesShareXHKGHKEX:DA20260430E00043
  • ●
    DirectorExecutives
    0HKEX
    11,000,000 sharesShareXHKGHKEX:DA20260430E00044

4 of 4 declarations

About Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd. is a company specializing in research and development services for the pharmaceutical industry. It offers integrated solutions ranging from drug discovery to manufacturing.